Icon Drugs Private Limited
About Icon Drugs Private Limited
Data last updated:
Icon Drugs Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 January 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24231MH2002PTC134479. Its GSTIN is 27AABCI1210L1ZW (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushrut Umesh Dange and Rachana Umesh Dange.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 1 Flat No. 201 Sai Dershan Complex Vivekanand Nagar Wardha Road, Nagpur, Maharashtra, India – 440015.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹9.97 Lakh (net margin 3.7%) and EBITDA of ₹22.76 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 12% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Icon Drugs Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 1 Flat No. 201 Sai Dershan Complex Vivekanand Nagar Wardha Road, Nagpur, Maharashtra, India – 440015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Icon Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Icon Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Icon Drugs Private Limited, buy the company report.
Financials of Icon Drugs Private Limited
FY 2025 filings availableIcon Drugs Private Limited reported revenue of ₹2.66 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 14% growth in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Icon Drugs Private Limited, buy the company report.
Board of directors of Icon Drugs Private Limited
Icon Drugs has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushrut Umesh Dange Also directs: Iconic Engineers Corporation LLP | Director | 27 Feb 2017 | 9 Years 8 Months | Current |
| Rachana Umesh Dange | Director | 15 Mar 2022 | 4 Years 7 Months | Current |
| Umesh Babanrao Dange | Director | 08 Jan 2002 | 24 Years 9 Months | Current |
| Srushti Umesh Dange | Director | 25 Jan 2025 | 1 Years 9 Months | Current |
Auditor
Icon Drugs Private Limited is audited by GANERIWALA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GANERIWALA & CO | FY 2023 | 000855S |
Shareholding
The shareholding of Icon Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Icon Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Nov 2010 | 10258295 | Ing Vysya Bank Limited | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Icon Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Icon Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Icon Drugs Private Limited has a workforce of 13 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Icon Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCI1210L1ZW | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Icon Drugs Private Limited, buy the company report.
Recent activity
Icon Drugs Private Limited has 11 board changes on record since 2002: 4 appointments and 7 cessations. The latest: Srushti Umesh Dange ceased to be Additional Director on 29 Sep 2025.
3 earlier events are in the company report.
Frequently asked questions
Icon Drugs is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 January 2002 (24+ years old) and is registered under CIN U24231MH2002PTC134479.
Icon Drugs has 4 current directors:
- Sushrut Umesh Dange - Director
- Rachana Umesh Dange - Director
- Umesh Babanrao Dange - Director
- Srushti Umesh Dange - Director
The latest financial statements of Icon Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Icon Drugs is 27AABCI1210L1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Icon Drugs is U24231MH2002PTC134479. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Icon Drugs was incorporated on 08 January 2002, making it 24+ years old. It is registered with the Registrar of Companies, Nagpur.
Srushti Umesh Dange ceased to be Additional Director on 29 Sep 2025. Srushti Umesh Dange was appointed as Director on 25 Jan 2025. Rachana Umesh Dange ceased to be Director on 29 Sep 2022. Icon Drugs has 11 board changes on record in total.
The registered office of Icon Drugs is at Plot No. 1 Flat No. 201 Sai Dershan Complex Vivekanand Nagar Wardha Road, Nagpur, Maharashtra, India – 440015.
Icon Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Icon Drugs has open charges of ₹25 Lakh and no satisfied charges on record as per latest MCA filings.